Portola Pharmaceuticals Announces Several Scientific Presentations at International Society on Thrombosis and Haemostasis XII Congress

...tary pipeline programs focused on the discovery and development of novel, specific Syk and JAK inhibitors to treat cancer and inflammatory diseases; a thromboxane receptor antagonist, which is an aspirin replacement product for patients intolerant to aspirin; and a novel anticoagulant antidote program with the p...

Corgenix to Exhibit AspirinWorks(R) Test at 2009 ISTH Meeting

...hat determines the effect of aspirin on platelets by measuring the level of thromboxane production (aspirin's target). The higher the levels of thromboxane, the st...it is an enzyme-linked immunoassay (ELISA) to determine levels of 11dehydro thromboxane B2 (11dhTxB2) in human urine, which aids in the qualitative detection of as...

Portola Pharmaceuticals to Host Conference Call at 11:00 a.m. Eastern Time Tomorrow to Discuss Betrixaban Partnership and Provide Corporate Update

...tary pipeline programs focused on the discovery and development of novel, specific Syk and JAK inhibitors to treat cancer and inflammatory diseases; a thromboxane receptor antagonist, which is an aspirin replacement product for patients intolerant to aspirin; and a novel anticoagulant antidote program with the p...

New Aspirin Test Now Available in Wichita Area

...ets by measuring the level of the biomarker called thromboxane B2 (11dhTxB2). The higher the levels of thromboxane B2, the stickier the blood platelets, and the less...is the only FDA-cleared test that measures urinary thromboxane B2 to accurately determine aspirin effect in appar...

Prostaglandin receptor key to atherosclerosis development

..."Our studies clearly show that prostaglandin-E2 plays an important role in atherosclerosis and in macrophage survival," Linton said. "Prostacyclin and thromboxane aren't the whole story." The findings suggest the potential for modulating the development of atherosclerosis with inhibitors of prostaglandin-E2 sy...

New CHARISMA Outcome Study Results Validate Aspirin Effect

...levated urinary levels of the biomarker 11-dehydro thromboxane B2 (11dhTxB2) indicate an increased risk of heart ...dy supports that measurement of urinary 11-dehydro thromboxane B2 can identify patients at risk for ischemic even...el (vs. placebo) did not reduce urinary 11-dehydro thromboxane B2 levels nor did it reduce the hazard of cardiova...

Breakthrough Testing for Patients on Aspirin Therapy for Preventing Heart Attacks

...uot; The new Aspirin Response Test (ART) measures a substance, thromboxane B2 which is associated with the formation of blood clots. Aspirin is suppo... of this substance in the body. "We know that aspirin is working when thromboxane B2 levels are very low," says Dr. Sciabbarrasi. "If they are not...

Corgenix to Exhibit AspirinWorks(R) Test at 2008 ACOFP Meeting in Denver

...hat determines the effect of aspirin on platelets by measuring the level of thromboxane production (aspirin's target). The higher the levels of thromboxane, the st...t is an enzyme-linked immunoassay (ELISA) to determine levels of 11 Dehydro thromboxane B2 (11dhTxB2) in human urine, which aids in the qualitative detection of as...

Passive Cigarette Smoking Increases Isoprostane Formation

...s of smokers. There was a significant correlation of 8-epi-PGF2a to the thromboxane (plasma, serum, conversion from exogenous precursor, 11-dehydro-TXB2) param... The authors conclude that besides activation of platelet function and the thromboxane synthesis, in vivo oxidation injury may be an important additional major pl...

Aspirin deflated

.../ Aspirin works by blocking the formation of thromboxane A2, a chemical in the body that makes platelets st...found that taking aspirin did not adequately block thromboxane in some people, making them 4 times more likely to...ers analyzed that aspirin did not adequately block thromboxane in some patients because of an underlying genetic ...

Thromboxane in Medical Technology

ALP Life Sciences, LLC Announces Nanoveson(TM) Patent Filing and Whitepaper Availability on Proposed Therapy for Non-Alcoholic Fatty Liver Disease (NAFLD) and Comorbid Diseases

...f arachidonic acid. There is extensive research focused on blocking arachidonic acid metabolism along cytochrome P450, leukotriene, prostaglandin, and thromboxane eicosanoid pathways. Arachidonic acid metabolism is implicated in many inflammatory diseases, including cardiovascular diseases, gastrointestinal di...

Corgenix AspirinWorks(R) Test Recognized in POLYCAP Study at ACC.09

...eared test that measures urinary 11dhTxB2 to accurately determine the effect of aspirin in apparently healthy individuals. 11dhTxB2 is a metabolite of thromboxane A2, the target of aspirin therapy. The AspirinWorks Test was launched in the U.S. in June 2007 following FDA 510(k) clearance, and it is now ava...

Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study

...mediated platelet activation without the liability of increased bleeding (when added to standard of care), a tendency associated with drugs that block thromboxane or ADP pathways. Specifically, this compound is being investigated as an oral antiplatelet agent for patients with established vascular disease, with ...

ViaViente Demonstrates Cardiovascular Benefits in New Human Trial

...tablished test to measure the reduction of thromboxane in human metabolism. thromboxane contributes to vasoconstriction, which can increase blood pressure, and pla...gher incidence of serious cardiovascular events. Reducing the production of thromboxane can help reduce vasoconstriction and platelet stickiness. Experts agree t...

Lifesaving Benefits of Low-Dose Aspirin Therapy Maintained With Naproxen Sodium

... criteria were given 81 mg of enteric- coated, low-dose aspirin once daily. After the first five days, all subjects demonstrated a 99 percent level of thromboxane (TXB2) inhibition. The group was then divided into three groups for an additional five days of treatment: -- The first group [n=12] continued on 81 ...

SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients

...mediated platelet activation without the liability of increased bleeding (when added to standard of care), a tendency associated with drugs that block thromboxane or ADP pathways. Specifically, this compound is being investigated as an oral antiplatelet agent for patients with established vascular disease, with ...

Thromboxane in Medical Products

Autologous Platelet Gel

Description:...anges involved in coagulation take place. Secreted from the platelets are a number of factors including serotonin, fibronectin, adenosine diphosphate, thromboxane A, platelet factor 4, platelet derived growth factor and platelet activating factor. Release of these factors cause a chemotactic response and initiat...
Company:Blood Recovery Systems, Inc.

Thromboxane in Biological News

Trans fats hinder multiple steps in blood flow regulation pathways

... converts the essential fatty acid linoleic acid into arachidonic acid, which is needed for the production of prostacyclin (a blood-flow enhancer) and thromboxane (which regulates the formation of blood clots needed for wound healing). While some in the food oil industry believed this problem could be overcome s...

Thromboxane in Biological Technology

Isolation of Low Molecular Weight Digestion Products of the Human Platelet Thromboxane A2 Receptor, Rev A

Joseph W. Turek and Guy C. Le Breton, Department of Pharmacology, University of Illinois at Chicago, College of Medicine, Chicago, IL 60612. Address correspondence to: Joseph W. Turek, 835 South Wolcott, Department of Pharmacology M/C 868, University of Illinois at Chicago, Chi...

Corgenix to Exhibit AspirinWorks(R) Test at ACC.09

...eared test that measures urinary 11dhTxB2 to accurately determine the effect of aspirin in apparently healthy individuals. 11dhTxB2 is a metabolite of thromboxane A2, the target of aspirin therapy. "The phenomenon of aspirin effect has been validated in numerous randomized, controlled prospective outcome t...

Nile Therapeutics Announces Focus on CD-NP for Acute Heart Failure and Termination of 2NTX-99 Program

...atelet, anti-atherothrombotic agent with nitric oxide donating properties. Mechanistically, 2NTX-99 is believed to inhibit the synthesis and action of thromboxane and enhance prostacyclin production. Prostacyclin and NO work together to inhibit platelet adhesion and aggregation, induce vasodilation and protect t...

Corgenix to Exhibit AspirinWorks(R) Test, Discuss New CHARISMA Trial Results at AHA 2008 Meeting

... 11-dehydro thromboxane B2 (11dhTxB2) levels affirmed as independent pr...levated urinary levels of the biomarker 11-dehydro thromboxane B2 (11dhTxB2) indicate an increased risk of heart ...y healthy individuals. 11dhTxB2 is a metabolite of thromboxane A2, the target of aspirin therapy. "The American...

Corgenix to Exhibit AspirinWorks(R) Test at ADA 2008 Meeting in San Francisco

...hat determines the effect of aspirin on platelets by measuring the level of thromboxane production (aspirin's target). The higher the levels of thromboxane, the st...t is an enzyme-linked immunoassay (ELISA) to determine levels of 11-Dehydro thromboxane B2 (11dhTxB2) in human urine, which aids in the qualitative detection of as...

Corgenix to Exhibit AspirinWorks(R) Test at ACC 2008 Meeting in Chicago

...hat determines the effect of aspirin on platelets by measuring the level of thromboxane production (aspirin's target). The higher the levels of thromboxane, the st...t is an enzyme-linked immunoassay (ELISA) to determine levels of 11 Dehydro thromboxane B2 (11dhTxB2) in human urine, which aids in the qualitative detection of as...

Celadrin(R) Research Unveiled at Nutrigenomics 2008 Meeting in Paris, France

...itro studies, Celadrin(R) was shown to inhibit the thromboxane synthase enzyme using prostaglandin G2 (PGG2) and ...s. To further elucidate the mechanism of action on thromboxane production, receptor binding assays were carried out on the thromboxane A2 membrane receptor. Celadrin(R) was found to exe...

Nile Therapeutics, Inc. to Present at Upcoming BIO Investor Forum

... option for heart failure patients. 2NTX-99 is a novel small molecule that has been shown in vivo and in vitro to inhibit the synthesis and action of thromboxane (TXA2), enhance the production of endothelial prostacyclin (PGI2) and supply a pharmacological amount of nitric oxide (NO) to the vasculature. Nile be...

Nile Therapeutics, Inc. Adds to Executive Management Team

... option for heart failure patients. 2NTX-99 is a novel small molecule that has been shown in vivo and in vitro to inhibit the synthesis and action of thromboxane (TXA2), enhance the production of prostacyclin (PGI2) and supply a pharmacological amount of nitric oxide (NO) to the vasculature. Nile believes that ...

Endotoxins and their Relevance in R&D ApplicationsLPS Detection & Removal Methods

...se of tumor necrosis factor (TNF), Interleukins-1,6 and 8 and the production of Platelet-activating factors, Prostaglandin E 2 , thromboxane A 2 7 8 . LPS Detection Today the LAL (Limulus Amebocyte Lysate) assay is used for the routine ...

Thromboxane in Biological Definition

Hormone

...vatives calcitriol Lipid and phospholipid hormones ( eicosanoids ): prostaglandins leukotrienes prostacyclin thromboxane One special group of hormones are trophic hormones that act as stimulants of hormone production of other endocrine glands . For example: t...

Thromboxane in Biological Dictionary

Prostaglandins

...dia ... Online Shopping at SpotCost.com - New and used books like Mass Spectra of Prostaglandins and Related Products Advances in Prostaglandin thromboxane and Leukotriene... Prostaglandins and related compounds are collectively known as eicosanoids. ... They inhibit formation of prostaglandins inv...